TR201716203A1 - Yeni umeklidinyum formülasyonları. - Google Patents

Yeni umeklidinyum formülasyonları. Download PDF

Info

Publication number
TR201716203A1
TR201716203A1 TR2017/16203A TR201716203A TR201716203A1 TR 201716203 A1 TR201716203 A1 TR 201716203A1 TR 2017/16203 A TR2017/16203 A TR 2017/16203A TR 201716203 A TR201716203 A TR 201716203A TR 201716203 A1 TR201716203 A1 TR 201716203A1
Authority
TR
Turkey
Prior art keywords
umeclidinium
formulations
new
treatment
relates
Prior art date
Application number
TR2017/16203A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/16233A priority Critical patent/TR201716233A2/tr
Priority to TR2017/16213A priority patent/TR201716213A1/tr
Priority to TR2017/16209A priority patent/TR201716209A2/tr
Priority to TR2017/16203A priority patent/TR201716203A1/tr
Priority to TR2017/16207A priority patent/TR201716207A2/tr
Priority to TR2017/16235A priority patent/TR201716235A2/tr
Priority to TR2017/16238A priority patent/TR201716238A1/tr
Publication of TR201716203A1 publication Critical patent/TR201716203A1/tr

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Mevcut buluş solunum yolları hastalıklarının tedavisinde kullanılacak umeklidinyum içeren farmasötik formülasyonlara ilişkindir.
TR2017/16203A 2017-09-30 2017-10-20 Yeni umeklidinyum formülasyonları. TR201716203A1 (tr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
TR2017/16233A TR201716233A2 (tr) 2017-09-30 2017-10-20 Solunum yolları hastalıklarının tedavisi için birden fazla etken madde içeren farmasötik bileşim.
TR2017/16213A TR201716213A1 (tr) 2017-10-20 2017-10-20 İndakaterol ile birlikte bir antikolinerjik etken madde içeren farmasötik bileşimler.
TR2017/16209A TR201716209A2 (tr) 2017-10-20 2017-10-20 Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler.
TR2017/16203A TR201716203A1 (tr) 2017-10-20 2017-10-20 Yeni umeklidinyum formülasyonları.
TR2017/16207A TR201716207A2 (tr) 2017-10-20 2017-10-20 Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar.
TR2017/16235A TR201716235A2 (tr) 2017-09-30 2017-10-20 Solunum Yolları Hastalıklarının Tedavisi İçin Birden Fazla Etken Madde İçeren Farmasötik Bileşim
TR2017/16238A TR201716238A1 (tr) 2017-10-18 2017-10-20 Yeni farmasötik bileşimler.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/16203A TR201716203A1 (tr) 2017-10-20 2017-10-20 Yeni umeklidinyum formülasyonları.

Publications (1)

Publication Number Publication Date
TR201716203A1 true TR201716203A1 (tr) 2019-05-21

Family

ID=67954794

Family Applications (3)

Application Number Title Priority Date Filing Date
TR2017/16203A TR201716203A1 (tr) 2017-09-30 2017-10-20 Yeni umeklidinyum formülasyonları.
TR2017/16207A TR201716207A2 (tr) 2017-10-18 2017-10-20 Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar.
TR2017/16209A TR201716209A2 (tr) 2017-09-30 2017-10-20 Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler.

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2017/16207A TR201716207A2 (tr) 2017-10-18 2017-10-20 Vilanterol ve umeklidinyum içeren farmasötik formülasyonlar.
TR2017/16209A TR201716209A2 (tr) 2017-09-30 2017-10-20 Arformoterol ve umeklidinyum içeren yeni farmasötik bileşimler.

Country Status (1)

Country Link
TR (3) TR201716203A1 (tr)

Also Published As

Publication number Publication date
TR201716207A2 (tr) 2019-05-21
TR201716209A2 (tr) 2019-05-21

Similar Documents

Publication Publication Date Title
MX2022001755A (es) Compuestos de dinucleotidos ciclicos y metodos de uso.
EA201790273A1 (ru) Флагеллиновые композиции и их применение
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
PH12016501139B1 (en) Bicyclic heterocycle compounds and their uses in therapy
EA201891083A1 (ru) Составы антител к cd38 для подкожного введения и их применение
TW201613901A (en) New compounds
IL255509B (en) Compounds as modulators of ccr2, pharmaceutical preparations containing them and their use in the treatment of diseases
EA201691582A1 (ru) Новые фармацевтические препараты
SA518391170B1 (ar) مركبات باي أريل مفيدة لعلاج الأمراض البشرية في علم الأمراض، طب الأعصاب وعلم المناعة
EA201692301A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201991484A1 (ru) Лекарственные формы энзалутамида
TR201900148T4 (tr) Kansere karşı yeni maddeler olarak sübstitüe edilmiş 2,4 diamino-kinolin.
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
MX2018008644A (es) Derivados de 3-((hetero)aril)-alquil-8-amino-2-oxo-1,3-diaza-espir o-[4.5]-decano.
MX2018004220A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
SG10201805646WA (en) Angiopoietin-like 4 antibodies and methods of use
CL2016002321A1 (es) Compuestos derivados del ácido 2-8-5-cloropirimidin-2-ilamino-6,7,8,9-tetrahidro-5h-pirido3,2-bindol-5-ilacético, moduladores del receptor de prostaglandina d2 composición farmacéutica y su uso para el tratamiento de enfermedadestrastornos alérgicosinmunitarios.
MX2018004217A (es) Tetrahidropiranilsulfonas sustituidas con pirazolilo.
TR201905218T4 (tr) Nörodejenerati̇f hastaliklarin tedavi̇si̇ i̇çi̇n yararli vi̇tanoli̇dler.
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
EA201892157A1 (ru) Фосфаплатиновые жидкие составы
ITUB20169928A1 (it) Formulazioni farmaceutiche per il trattamento del diabete
TR201716203A1 (tr) Yeni umeklidinyum formülasyonları.